Healthcare -
Biotechnology - NASDAQ - CA
$ 1.75
0 %
$ 77.6 M
Market Cap
-2.73
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
ESSA Pharma Inc.
| Net Income | -28.5 M |
| Depreciation & Amortization | 0 |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 6.54 M |
| Change in Working Capital | -419 K |
| Others | -712 K |
| Free Cash Flow | -22.7 M |
Cash Flow
Millions
| Sep-2024 | Sep-2023 | Sep-2022 | Sep-2021 | Sep-2020 | Sep-2019 | Sep-2018 | Sep-2017 | Sep-2016 | Sep-2015 | Sep-2014 | Sep-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||
| Net Income | (28.5) | (26.6) | (35.1) | (36.8) | (23.4) | (10.4) | (11.6) | (4.7) | (13.1) | (8.6) | (1.8) | 1.37 K | 1.94 K |
| Depreciation & Amortization | 0 | 0.1 | 0.1 | 0.1 | 0.1 | 18.3 K | 34.5 K | 46.1 K | 66.2 K | 39.1 K | 23.4 K | 24.6 | 25.4 |
| Deferred Income Tax | 0 | 0 | 0 | (0.1) | (0.2) | 15 K | 47.7 K | (7.3) | (6.7) | 24.2 K | 42.9 K | 0 | 0 |
| Stock Based Compensation | 6.5 | 5.0 | 7.89 K | 9.48 K | 7.52 K | 1.15 K | 1.4 | 0.8 | 1.2 | 1.3 | 0.5 | 322 | 87.8 |
| Other Operating Activities | (0.3) | (0.7) | (0.8) | 35.3 K | 0.2 | (1.7) | 0.7 | (4.4) | 0.9 | (5.2) | (1.1) | 67.3 | 89.1 |
| Change in Working Capital | (0.4) | 2.3 | (0.8) | 1.9 | (1.2) | (1.3) | (0.7) | (1.7) | 2.3 | 84.4 K | 0.3 | 194 | 84.3 |
| Cash From Operations | (22.7) | (19.8) | (28.7) | (25.4) | (17.0) | (12.2) | (10.2) | (17.4) | (15.3) | (12.3) | (2.1) | 763 | 1.82 K |
| INVESTING CASH FLOW | |||||||||||||
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.98 K | (0.2) | 0 | 0 | 0 |
| Other Items | 91.8 | (3.5) | (52.3) | (35.0) | (21.7) | 45.5 K | (0.2) | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 91.8 | (3.5) | (52.3) | (35.0) | (21.7) | 45.5 K | (0.2) | 0 | 9.98 K | (0.2) | 0 | 0 | 0 |
| FINANCING CASH FLOW | |||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | (0.1) | (0.1) | (0.1) | (4.0) | (2.8) | (2.0) | 8.0 | 0 | 0 | 0.9 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.9 | 68.7 K | 0.4 | (7.9) | (3.2) | 17.8 | (2.7) | 4.3 | 2.7 | (0.6) | 2.6 | 0 | 2.4 K |
| Cash From Financing Activities | 0.9 | 68.2 K | 0.3 | 142.0 | 41.8 | 50.8 | 21.3 | 12.3 | 22.7 | 11.1 | 5.7 | 0 | 2.4 K |
| CHANGE IN CASH | |||||||||||||
| Net Change In Cash | 70.0 | (23.4) | (80.7) | 81.5 | 3.0 | 38.5 | 10.9 | (5.0) | 7.4 | (1.5) | 3.5 | 763 | 574 |
| FREE CASH FLOW | |||||||||||||
| Free Cash Flow | (22.7) | (19.8) | (28.7) | (25.4) | (17.0) | (12.2) | (10.2) | (17.4) | (15.3) | (12.5) | (2.1) | 763 | 1.82 K |